2'-tBDSilyl Uridine CED phosphoramidite

2'-tBDSilyl Uridine CED phosphoramidite

Catalog Number:
NAS1056008CHE
Mfr. No.:
ANP-5674
Price:
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

      • Properties
        • Categories
          TBDMS RNA Amidites and Supports, Standard Protection
          Molecular Formula
          C45H61N4O9PSi
          Molecular Weight
          861.050
          Shipping
          This material is sensitive to heat and moisture. It requires the fastest shipment possible.
      • Applications
        • Application Description
          RNA Synthesis:

          The importance of RNA has long been recognized in cellular processes. A major area of focus is on antisense RNA1 and the role of catalytic RNA in splicing and ligation.2 Chemical synthesis of defined sequence RNA is fundamental to develop and understand the role and application of RNA. The enzymatic approach using RNA polymerase is template dependant and is therefore not a controlled sequence synthesis.3 Chemical synthesis of RNA has been perfected to the extent that long sequences, such as biologically active 76-mer tRNA and multi-milligram quantities can be produced efficiently.4

          Small Interference RNA:

          Since the first description of this process in the nematode C. elegans5 RNAi has become a powerful and widely used tool for gene down regulation and Andrew Fire and Craig Mello were awarded the Nobel Prize in medicine for the year 2006 in an honor of developments in RNAi mechanism. RNAi pathway is initiated by an endogenous ribonuclease enzyme called Dicer, which process long dsRNA molecules into short fragments of 21–23-nucleotide long siRNA molecules with the two nucleotide 3’overhanging ends. The siRNA molecules incorporated into RNA-induced silencing complex (RISC), where one of the two siRNA strands get unwinds. The single-stranded antisense molecule that is associated in RISC, sequence selectively binds to the specific mRNA transcript and an endonuclease from this complex cleaves the target mRNA. From the last few years, siRNA approach has become the preferred method for gene down regulation in many academic and industrial laboratories and it holds great therapeutic application for gene silencing.6

          The RNAi offers astronomical potentials for understanding and manipulating human diseases at the cellular level. Among the vast and rapidly exploding field of siRNA, some key developments in this area are prediction of natural regulatory mechanism in the field of cell biology and functional genomics. This is expected to result in gene based drug discovery. Gene control, gene knock down, and target validation are currently being persued with great vigor by a vast number of researchers worldwide. Short dsRNA’s can be best obtained by Chemical synthesis. We offer the highest purity RNA monomers for studies and further developments in this field.

          Use of Ethylthio Tetrazole (ETT) and Benzylthio Tetrazole (BMT):

          The use of ETT or BTT as an activator in RNA synthesis has been shown to enhance coupling efficiency in each step.7

          References:

          1. Hëléne, C.; Toulme, J. J. Biochim. Biophys. Acta 1990, 99, 1049.

          2. a) Cech, T. R. Science 1987, 236, 1532; b) Guerrier-Takadac, N.; Altman, L. S. Science 1989, 246, 1578.

          3. Milligan, J. F.; Groebe, D. R.; Witherell, G. W.; Uhlenbeck, O. C. Nucl. Acids Res. 1987, 15, 8783.

          4. a) Gasparuto, D.; Livache, T.; Bazin, H.; Duplaa, A.; Guy, A.; Khorlin, A.; Molko, D.; Roget, A.; Teoule, R. Nucl. Acids Res. 1992, 20, 5159; b) Webster, K. R.; Shamoo, Y.; Königsberg, W.; Spicer, E. K.; Biotechniques 1991, 11, 658.

          5. Fire, A.; Xu, S.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C.Nature 1998, 391, 806-811.

          6. a) Dorsett, Y.; Tuschl, T. Nat. Rev. Drug Disc. 2004, 3, 318-329; b) Uprichard, S.L. FEBS Lett. 2005, 579, 5996-6007.

          7. Wasner, M.; Arion, D.; Borkow, G.; Noronha, A.; Uddin, A. H.; Parniak, M. A.; Damha, M. J. Biochemistry 1998, 37, 7478-7486.

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
  • Copyright © Amerigo Scientific. All rights reserved.